{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:19:02Z","timestamp":1787584742058,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Marmara University Scientific Research Projects Commission","award":["BAPKO, Project ID: 10980"],"award-info":[{"award-number":["BAPKO, Project ID: 10980"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02254-6","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:18:16Z","timestamp":1775798296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advanced glycation end-products and sclerostin are elevated across diabetes phenotypes and associated with vertebral fractures in type 2 diabetes"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-244X","authenticated-orcid":false,"given":"Sevdenur","family":"Taskin Kursun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-7133","authenticated-orcid":false,"given":"Eren","family":"Imre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6313","authenticated-orcid":false,"given":"Dilek","family":"Gogas Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"4","key":"2254_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus\u2013induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208\u201319. [PMID: 28148954].","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2254_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int. 2007;18(4):427\u201344. [PMID: 17160467].","journal-title":"Osteoporos Int"},{"issue":"1","key":"2254_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1507\/endocrj.EJ22-0116","volume":"70","author":"M Yamamoto","year":"2023","unstructured":"Yamamoto M, Sugimoto T. Bone fragility in type 1 diabetes mellitus. Endocr J. 2023;70(1):13\u201326. [PMID: 36477131].","journal-title":"Endocr J"},{"issue":"5","key":"2254_CR4","first-page":"597","volume":"98","author":"Y Fan","year":"2023","unstructured":"Fan Y, Wei F, Lang Y, Liu Y. Diabetes mellitus and risk of bone fractures: a meta-analysis. Clin Endocrinol (Oxf). 2023;98(5):597\u2013610. [PMID: 36900588].","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2254_CR5","first-page":"258","volume":"17","author":"AJ Burghardt","year":"2019","unstructured":"Burghardt AJ, Kazakia GJ. Defining the structural mechanisms of diabetic bone disease. Curr Osteoporos Rep. 2019;17(5):258\u201368. [PMID: 31376019].","journal-title":"Curr Osteoporos Rep"},{"key":"2254_CR6","doi-asserted-by":"publisher","unstructured":"Elizabeth M, Curtis RJ, Moon SD\u2019Angelo, Raisi-Estabragh Z, Cooper C, Harvey NC. Type 1 and 2 diabetes mellitus: comprehensive fracture risk relationships in UK Biobank. J Bone Miner Res. November 2025;40(11):1246\u201354. https:\/\/doi.org\/10.1093\/jbmr\/zjaf094.","DOI":"10.1093\/jbmr\/zjaf094"},{"issue":"10","key":"2254_CR7","first-page":"1903","volume":"37","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto M, et al. Advanced glycation end-products and bone strength in diabetes mellitus. J Bone Min Res. 2022;37(10):1903\u201315. [PMID: 36028078].","journal-title":"J Bone Min Res"},{"key":"2254_CR8","first-page":"115971","volume":"150","author":"R Sanguineti","year":"2021","unstructured":"Sanguineti R, et al. Effects of pentosidine accumulation on bone cell differentiation. Bone. 2021;150:115971. [PMID: 34197924].","journal-title":"Bone"},{"key":"2254_CR9","doi-asserted-by":"publisher","unstructured":"Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, Napoli N, Mithal A, Chakhtoura M. Ghada El-Hajj Fuleihan, Serge Ferrari, biochemical markers of bone fragility in patients with diabetes. J Clin Endocrinol Metabolism. October 2023;108(10):e923\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgad255.","DOI":"10.1210\/clinem\/dgad255"},{"key":"2254_CR10","first-page":"116921","volume":"175","author":"Y Hamada","year":"2023","unstructured":"Hamada Y, et al. Accumulation of advanced glycation end-products in femoral head of patients with type 2 diabetes and hip fracture. Bone. 2023;175:116921. [PMID: 36948342].","journal-title":"Bone"},{"issue":"3","key":"2254_CR11","first-page":"e1410","volume":"109","author":"BJ Kim","year":"2024","unstructured":"Kim BJ, et al. Serum sclerostin levels are associated with increased risk of vertebral fractures in type 2 diabetes. J Clin Endocrinol Metab. 2024;109(3):e1410\u20138. [PMID: 38100912].","journal-title":"J Clin Endocrinol Metab"},{"key":"2254_CR12","first-page":"1149961","volume":"14","author":"C Poiana","year":"2023","unstructured":"Poiana C, et al. Sclerostin: a key mediator of diabetic bone disease. Front Endocrinol (Lausanne). 2023;14:1149961. [PMID: 36922125].","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2254_CR13","first-page":"e3684","volume":"40","author":"I Kramer","year":"2024","unstructured":"Kramer I, et al. Divergent skeletal effects of sclerostin in latent autoimmune and type 2 diabetes. Diabetes Metab Res Rev. 2024;40(5):e3684. [PMID: 38271945].","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2254_CR14","first-page":"817","volume":"38","author":"K Tanaka","year":"2023","unstructured":"Tanaka K, et al. AGE\u2013RAGE signaling induces SOST expression and osteocyte apoptosis in diabetic bone. J Bone Min Res. 2023;38(5):817\u201329. [PMID: 37309812].","journal-title":"J Bone Min Res"},{"key":"2254_CR15","unstructured":"International Society for Clinical Densitometry (ISCD). 2019 ISCD Official Positions - Adult. https:\/\/iscd.org\/wp-content\/uploads\/2021\/09\/2019-Official-Positions-Adult-1.pdf. Accessed 3 Mar 2026."},{"issue":"9","key":"2254_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, Van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Min Res. 1993;8(9):1137\u201348.","journal-title":"J Bone Min Res"},{"issue":"1","key":"2254_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.numecd.2022.10.004","volume":"33","author":"E Cairoli","year":"2023","unstructured":"Cairoli E, et al. Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2023;33(1):158\u201367.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"2254_CR18","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00198-017-4097-x","volume":"28","author":"VN Shah","year":"2017","unstructured":"Shah VN, Harrall KK, Shah CS, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int. 2017;28(9):2601\u201310. https:\/\/doi.org\/10.1007\/s00198-017-4097-x.","journal-title":"Osteoporos Int"},{"issue":"3","key":"2254_CR19","doi-asserted-by":"publisher","first-page":"e3390","DOI":"10.1002\/dmrr.3390","volume":"37","author":"Y Hu","year":"2021","unstructured":"Hu Y, Li X, Yan X, Huang G, Dai R, Zhou Z. Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes. Diabetes Metab Res Rev. 2021;37(3):e3390. https:\/\/doi.org\/10.1002\/dmrr.3390.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"2254_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2337\/dc12-1188","volume":"36","author":"L Oei","year":"2013","unstructured":"Oei L, Zillikens MC, Dehghan A, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013;36(6):1619\u201328. https:\/\/doi.org\/10.2337\/dc12-1188.","journal-title":"Diabetes Care"},{"key":"2254_CR21","doi-asserted-by":"publisher","unstructured":"Strotmeyer ES, Cauley JA, Schwartz AV, et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med. 2005;165(14):1612\u20131617. https:\/\/doi.org\/10.1001\/archinte.165.14.1612.","DOI":"10.1001\/archinte.165.14.1612"},{"key":"2254_CR22","doi-asserted-by":"publisher","unstructured":"Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455-468 https:\/\/doi.org\/10.2147\/TCRM.S131945.","DOI":"10.2147\/TCRM.S131945"},{"issue":"3","key":"2254_CR23","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1530\/EC-18-0456","volume":"8","author":"AK Picke","year":"2019","unstructured":"Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019;8(3):R55\u201370. https:\/\/doi.org\/10.1530\/EC-18-0456.","journal-title":"Endocr Connect"},{"key":"2254_CR24","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/boneres.2016.1","volume":"4","author":"MR Rubin","year":"2016","unstructured":"Rubin MR, Patsch JM. Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions. Bone Res. 2016;4:16001. https:\/\/doi.org\/10.1038\/boneres.2016.1. Published 2016 Mar 22.","journal-title":"Bone Res"},{"issue":"4","key":"2254_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208\u201319.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2254_CR26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/dc12-1355","volume":"36","author":"VV Zhukouskaya","year":"2013","unstructured":"Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, Shepelkevich AP, Zhurava IV, Korolenko GG, et al. Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013;36(6):1635\u201340.","journal-title":"Diabetes Care"},{"issue":"37","key":"2254_CR27","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.3346\/jkms.2021.36.e239","volume":"36","author":"SY Park","year":"2021","unstructured":"Park SY, Choi KH, Jun JE, Chung HY. Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts. J Korean Med Sci. 2021;36(37):e239. https:\/\/doi.org\/10.3346\/jkms.2021.36.e239. Published 2021 Sep 27.","journal-title":"J Korean Med Sci"},{"key":"2254_CR28","doi-asserted-by":"publisher","unstructured":"Jessica R, Furst LC, Bandeira W-W, Fan S, Agarwal, Kyle K, Nishiyama, Donald J, McMahon E, Dworakowski H, Jiang SJ, Silverberg MR, Rubin. Advanced glycation endproducts and bone material strength in type 2 diabetes. J Clin Endocrinol Metabolism. June 2016;101(6):2502\u201310. https:\/\/doi.org\/10.1210\/jc.2016-1437.","DOI":"10.1210\/jc.2016-1437"},{"issue":"3","key":"2254_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jocd.2021.11.010","volume":"25","author":"DG Yavuz","year":"2022","unstructured":"Yavuz DG, Apaydin T. Skin autofluorescence is associated with low bone mineral density in type 2 diabetic patients. J Clin Densitom. 2022;25(3):373\u20139. https:\/\/doi.org\/10.1016\/j.jocd.2021.11.010.","journal-title":"J Clin Densitom"},{"issue":"4","key":"2254_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MED.0000000000000733","volume":"29","author":"J Kaur","year":"2022","unstructured":"Kaur J, Khosla S, Farr JN. Effects of diabetes on osteocytes. Curr Opin Endocrinol Diabetes Obes. 2022;29(4):310\u20137. https:\/\/doi.org\/10.1097\/MED.0000000000000733.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"2254_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5051\/jpis.2015.45.3.101","volume":"45","author":"J Kang","year":"2015","unstructured":"Kang J, Boonanantanasarn K, Baek K, et al. Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner. J Periodontal Implant Sci. 2015;45(3):101\u201310. https:\/\/doi.org\/10.5051\/jpis.2015.45.3.101.","journal-title":"J Periodontal Implant Sci"},{"issue":"12","key":"2254_CR32","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/jbmr.4153","volume":"35","author":"A Piccoli","year":"2020","unstructured":"Piccoli A, Cannata F, Strollo R, et al. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes. J Bone Min Res. 2020;35(12):2415\u201322. https:\/\/doi.org\/10.1002\/jbmr.4153.","journal-title":"J Bone Min Res"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02254-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:03:09Z","timestamp":1778727789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02254-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02254-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cross-sectional case\u2013control study was approved by the Ethics Committee of Marmara University (Protocol No. 09.2022.1402; Approval Date: 09 November 2022) and supported by the Marmara University Scientific Research Projects Commission (BAPKO, Project ID: 10980). The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}